PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2013-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 89
- Registration Number
- NCT01825447
- Locations
- 🇺🇸
Pfizer Investigational Site, Salt Lake City, Utah, United States
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 25
- Registration Number
- NCT01821066
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01821079
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
- Conditions
- Cerebral Amyloid Angiopathy
- Interventions
- Biological: PonezumabOther: placebo
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT01821118
- Locations
- 🇺🇸
Barnes Jewish Hospital, St. Louis, Missouri, United States
🇺🇸Boston Medical Center - Menino Pavilion, Boston, Massachusetts, United States
🇫🇷CHRU de Lille, Lille Cedex, NAP, France
Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01819922
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2014-01-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 5271
- Registration Number
- NCT01819935
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 266
- Registration Number
- NCT01815424
- Locations
- 🇨🇳
Dept. Of dermatology &STD, Beijing Friendship Hospital, Capital Medical University, Xicheng District, Beijing, China
🇨🇳Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
🇨🇳Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male Subjects
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT01812265
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
- Conditions
- Pneumococcal Diseases
- Interventions
- Other: There is no intervention in this study
- First Posted Date
- 2013-03-14
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 922
- Registration Number
- NCT01810861
- Locations
- 🇹🇷
Dokuz Eylul University Medical Faculty, Department of Chest Diseases, Balcova, Izmir, Turkey
🇹🇷Sami Ulus Kadin Dogum Cocuk Sagligi ve Hastaliklari Egitim Arastirma Hastanesi, Ankara, Turkey
🇹🇷Antalya Egitim ve Arastirma Hastanesi Tibbi Mikrobiyoloji, Antalya, Turkey
A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
- Conditions
- Nosocomial Pneumonia (NP)Ventilator-associated Pneumonia (VAP)
- Interventions
- Drug: ceftazidim-avibactam (CAZ-AVI, experimental product)
- First Posted Date
- 2013-03-11
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 969
- Registration Number
- NCT01808092
- Locations
- 🇻🇳
Research Site, Hochiminh, Vietnam